Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart cafraglutide; ...

We invite you to touch the objects on the surface of the flat files and to open each drawer to explore aspects of the changing relationship between people and land within what is today the extended ...

Edtech unicorn plans Rs 3,100 crore fresh issue and Rs 720 crore OFS as it gears up for growth and expansion Edtech unicorn PhysicsWallah has filed its updated draft red herring prospectus (DRHP) with ...

Promoters Green Meadows Investments and Anuradha Koduri, along with investor John Anthony Dexheimer, will offload part of their holdings in the OFS Indo-MIM, a Bengaluru-based manufacturer of ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who ...